PEN
Penumbra is a global healthcare company focused on innovating novel medical technologies to improve patient outcomes. The company develops neurovascular and vascular interventional devices for ischemic stroke and other cerebrovascular and vascular conditions, with operations and markets spanning internationally. Its portfolio includes devices for reperfusion, embolization, and vascular access, and the organization emphasizes research, clinical evidence, and patient impact. Penumbra’s content indicates a US-centric audience with a presence in multiple regions and a commitment to advancing interventional neuroradiology and vascular therapies.
No recent deals for this company.